Episode Transcript
Available transcripts are automatically generated. Complete accuracy is not guaranteed.
Speaker 1 (00:23):
Tell us some ben you see right there on the street.
That's a big trader trio t t T best in
the business of some of them. That's right, No lessons
self taught. Actually seventy five percent of some fire everybody
else costin Mary mcgodlin, Greg tdter Rod here at.
Speaker 2 (00:39):
The bar is a big b show continues.
Speaker 1 (00:41):
Of course, Sully big had it to you? How had
a big old hoby to you? Howie fuck our market
analysts here on the Big Bus show flew in from
New York last night.
Speaker 3 (00:49):
So glad to be here.
Speaker 2 (00:50):
Are your arms tired?
Speaker 3 (00:52):
Yeah?
Speaker 1 (00:53):
Your hair looks so good?
Speaker 2 (00:54):
See I did the dad jokes. Your hair looks this
is so good.
Speaker 1 (00:57):
Does it never look bad? No, but it's it's like
a different good this time. Don't you think it's not
as poofy on the side. I know, I told him,
I said, shortened to sign.
Speaker 2 (01:05):
That's the cow look he's going for welcome, thank you,
thank you very much.
Speaker 4 (01:09):
I thought, Uh, Well, in Rome, you know's wearing.
Speaker 5 (01:12):
The tussle, blocked the wardrobe to go so cow because
the wardrobe is No, he's.
Speaker 1 (01:17):
Very Menlo Park, He's very San Francisco Menlo Park.
Speaker 2 (01:20):
Well, I don't know, I'll get it.
Speaker 3 (01:21):
I'll get it. I paid that.
Speaker 1 (01:27):
I don't know.
Speaker 3 (01:27):
I don't know anybody about his phone.
Speaker 1 (01:32):
Somebody's phone. Okay, So we were just talking about the
Draw the Line initiative whereby college athletes are getting hassled
on campus by college students who bet on the games
and with is my phone?
Speaker 3 (01:46):
Isn't?
Speaker 1 (01:47):
It's a long story short. How much money is being
bet on? Who point seven billion dollars?
Speaker 3 (01:54):
And the market?
Speaker 1 (01:56):
This is on marks Man, Wow, march Man. He used
to call it the n I T tournament was called
now no march madness. Is the NCAA is separate from
the National Invatition what they used to call it something else.
It's not called Marx Maddis. It's called something else. It's
called the tournament, the tournament. But what tournament is it?
Speaker 3 (02:11):
Though?
Speaker 2 (02:12):
The NCAA champions You.
Speaker 1 (02:13):
Know what's interesting is I love about the NCAA Championship
is it their tournament? Is that every year there was
like a truck master school of trucking made it in
totally Marshall, Bourdeen, you know magic school. Like there's always
a school you never heard of them that gets in.
You know what this year is University of California San
Diego Tritons. Triton one of the hardest schools to get
(02:33):
into because it's a med school. Their basketball team ranks
ahead of Santio State, who's basically okay, out of sixty
four teams, you're never sixty six, you're allowed to play it.
UCSD's in the tournament because they moved up to Division
one and in their first year of eligibility they won
their turn. They won their conference tournament and got the
automatic bid into the field of sixty. I realized you
(02:56):
might be watching US in New York City, if you're
watching US overseas or something like that. Our studios in
San Diego, so were homeber So enough about not about
San Diego. What do you think about the Potters? No,
but but but for this tournament. Yeah, there's a lot
of money on the line here and and so at
the same time they're playing a p s A. Hey,
how he's up on the quarterback over there, you know,
(03:17):
But it's not a problem.
Speaker 4 (03:20):
I'm happy to draw the line whenever he's needed, wherever
is needed at all times.
Speaker 3 (03:26):
When you're you're a Florida State, I was at Florida State.
Speaker 4 (03:28):
Yeah, so That's that's my contribution here. The rest of
it is like how you guys feel during one of my.
Speaker 1 (03:32):
What was what was it? Did you see college athletes
on campus?
Speaker 4 (03:37):
You were because you were? Yeah, I mean it was like,
are they accessible? I was there when Florida State were
we're football champions, Jameis Winston. I was right there when
Jameis Winston walked out.
Speaker 1 (03:49):
Of a grocery store the legs. Yeah, that was my
groceries crab leg story. Uh, he forgot to pay for
crab legs. He just thought, well, I'm Jameis Winston. I
don't have to pay for these an.
Speaker 2 (04:02):
He walked pretty much the story.
Speaker 1 (04:04):
Yeah, now he's the proprietor of Jameis Winston Seafood Lobster.
Speaker 4 (04:11):
But all over the you know, seminole nation, Twitter handles
and news feeds and all that, there's all these stories
about athletes. You know, you were talking about parlays earlier
in the in the sports betting at least screwing up
people's like four part parlays or something. Yeah, and there's
and people are sending Venmo requests to them.
Speaker 1 (04:32):
Yeah, this is what they're talking about. So this is
the draw the line Okay, well, that's that's a vendor request.
What about how he fought in the back of the
class with the lead pipe swinging in his hand, waiting
for the no way to say, I will argue because
I'm part of this culture. Sometimes I would rather have
a lead pipe guy than I could avoid, probably than
(04:53):
fifty thousand ding ding ding. I can't even answer the phone.
That's that's a former harassment. I tell you on the
other side of the coin, what I think these college
students are are seeing and it is because of the
nil uh name, image likeness. What that means is now
you know. So the two sides of that story. N
C double A makes a billion dollars a year, is
(05:15):
a not for profit. Coaches make eight Look at they
just fired the coach of the Minnesota junior college basketball
team was making it's settled for three million dollars. Okay,
athletes who can pay jack and they're on the they're
on the cover Sports Illustrated and the Wheaty's box. Finally
they get to capitalize. Now that's a double edged sword
as well. Somebody suonents say, look, you're making three million
dollars by me and you get paid to go to
school and you're not even the NFL yet.
Speaker 4 (05:37):
Oh, boosters pay their more coaches mortgages.
Speaker 1 (05:39):
Yeah, so that's you realize that's where it's coming from.
At some point there's a have by have not. Yes,
But I find it so interesting that now there's a
PSA that's playing on NBA when you watch an NBA game,
yeah yeah, And and of course during the tournament here, well,
it all has to do with the number of the
dollar a mount for him yeathetic. And I think that,
you know, once you get to the pros, it's like, hey,
comes the territory man, night in, night out, someone's going
(06:01):
to be hating your guts. But college kids, and it's
to avoid in class, You're trying to just get your
lunch somewhere in the cafeteria and someone walks up to
you and goes, hey jack hole.
Speaker 2 (06:12):
Right, you know, wait to miss.
Speaker 5 (06:13):
Aren't as accessible as you're because you could.
Speaker 1 (06:16):
Be chemistry class, right, yeah, you chemstry classes.
Speaker 3 (06:19):
And I think it's more.
Speaker 4 (06:21):
I think it's more the it kind of takes away
the whole school experience that what was left was the
social aspect for the for the athletes. But otherwise, I mean,
especially the big schools, they're so separate. They all kind
of take the same electives or and they're in a
different dorm and they have I mean, they're already kind
of these other world that people.
Speaker 2 (06:40):
It's kind of you mean, they're already pros.
Speaker 4 (06:42):
Yeah, you're it's a rare event to see them walking around.
Speaker 1 (06:46):
But is there a vifrecation like you do they have
classes that that that you're in.
Speaker 4 (06:51):
No, it happens, but at these big schools, it's like
you have to be in that.
Speaker 1 (06:56):
So basically what they're doing. So so I wonder if
it's a digital belief, you know, like a cyber bullying,
it's got to be because you know, and and or
just or social media bulling, right man, I mean that's
you know, that's the people patrol sitting behind there. It's
also very hard to hide a whole football team, a
basketball team, it's easier. So these guys a lot of schools,
guys are out on campus and stuff. And if you're
(07:18):
stupid enough to go get into a six seven three
pounds offensive tackles face because the team lost, then you
have fun with that. But again, I think it's the
cyber bullying part. That's how many people came to his
birthday party. You remember the movie, remember the movie Draft Day? Shoot,
sorry brain farting right, there was that the color Kevin
(07:44):
he had numb one draft pick. No, we would take
him and and and the so he said, does this happen?
By the way, do they send out private investigators to
check these guys? Look at their shorts? That one thousand
percent so NBA, NFL, MLB. If they're looking at a
prospect young man, seems all good. Yeah, but they so
they look up a shorts with the flashlight. They find
out there Because the premise of the story was is
(08:06):
this first time draft drafts? He seemed like a perfect guy,
looked like Tom Brady and everything else. But why don't
people tell you there's something untold? And and uh And
the private eye goes up and figures out at his
twenty first birthday party, none of the team came red
flag red flag?
Speaker 2 (08:21):
Yeah, how do you.
Speaker 1 (08:22):
Looking at his birthday party? So to wrap this up,
Draft Kings Fan Duel and what is our prize picks?
What are the difference between those three betting operations.
Speaker 2 (08:31):
They're all the same. It's daily fantasy.
Speaker 1 (08:33):
You can, I can your first game of the NCAA tournament,
mister Sullivan coming up on Thursday. I've never played fantasy sports.
In my mind, I can go I can go in
and lay one hundred bucks. Say you're either going to
score over eighteen points as an individual. As an individual,
I can say, I think Bob's going to score over.
Speaker 2 (08:50):
Eighteen points. Nope, he's going to score under eighteen.
Speaker 3 (08:52):
You ever done fantasy Wow? Never have you done? Howie? No?
Speaker 2 (08:56):
I can I ask, though I've heard that.
Speaker 4 (08:59):
I've read that five percent of the highest most volume
betters are responsible for like eighty percent of these guys.
Speaker 2 (09:07):
Is that what it is?
Speaker 4 (09:07):
I mean, you've got people putting in their life saving
the whales.
Speaker 1 (09:11):
The whales are doing it, and then you know, and
again you bet. They always tell you only bet as
much as you can lose, afford to lose, never chase.
That's like saying only loan your relatives money that you
don't want to get best exactly. It's it's like saying,
eat one potato chip once you open the I don't
eat anymore. I think you mean funyan or funy and sorry, sorry,
you're right funy. The So at the end of the day,
(09:33):
does this kill I mean could this be turning the
tides in in online betting. Nothing's gonna turn the tizelne
Bedy Mary said it best.
Speaker 2 (09:39):
It's like, hey, don't litter. It's the don't litter campaign.
Speaker 1 (09:42):
Okay, really it's true recycle please.
Speaker 6 (09:48):
Right.
Speaker 1 (09:49):
It's almost like when they're playing the beer commercials for
for uh, you know, when when you're watching the Super.
Speaker 2 (09:53):
Bowl, drinks responsibly, you know, drink responsible. N got to
say it to cover there. Yeah, right, well they do.
Speaker 4 (10:03):
They could care less, but betting on it does make
it more fun, right, I mean like even a five dollars,
I mean, that's that's what.
Speaker 2 (10:11):
That's the pushback, right, you shouldn't put your mortgage payment.
But also like fifty bucks is fun, that's awesome.
Speaker 5 (10:17):
I like to see the bracket and just bet on
the bracket.
Speaker 1 (10:20):
The bracket thing, it's like such a that's such a
low percentage shot. Yeah, there's sixty four teams. I just
feel I'm tired of feeling. Well, the thing is about
the bracket, the two point seven million that's bet legally,
the amount of money that's bet illegally.
Speaker 2 (10:38):
Shoes well kind of thing like office pools care.
Speaker 3 (10:44):
Which we all make. I don't know. Oh, thanks a
lot for being the.
Speaker 1 (10:52):
So so much illegal money bet on it.
Speaker 3 (10:56):
But it's a minute.
Speaker 1 (11:20):
Big this show, another beautiful day here in southern California
where are inside the lack one hundred studios. That music
you hear in the background is the world famous, incredibly
talented day Trader Trio. We are lucky enough to be
able to sit and listen to these guys every single
(11:41):
episode of.
Speaker 3 (11:43):
The Big Biz Show.
Speaker 2 (11:44):
It is Mary burg.
Speaker 1 (11:45):
Goblin, I am costa little mini edition of None of Business.
Sully will be back in just a second, gentlemen, thank
you as always, and Mary, we always love talking with
our next guest, John. You is the CEO Cairo's Pharma
and their ticker symbol is Kapa. And doctor U joins
us once again here on The Big Biz Show. Doctor
(12:08):
how are you sir?
Speaker 2 (12:09):
It is always great to have.
Speaker 3 (12:10):
You on the program.
Speaker 2 (12:11):
I hope everything's going well for you this summer.
Speaker 7 (12:13):
I'm doing good. Thank you, Mike, thanks for having me again.
Speaker 1 (12:16):
The last time you were on. Since the last time
you were on with us, we have picked up a
ton of new platforms where people can go and view
and listen to The Big Bis Show. So since we're
kind of in that mode right now. Can you just
give people quick the nickel version of what you and
Chiro's Pharma are all about and what you do.
Speaker 7 (12:36):
Yeah, sure, we're Chiros Pharma. Our KAPA on the nysc
American is a clinical stage biotech company that's focused on
reversing cancer drug resistance. So one of the biggest problems
in cancer is that the drugs are great, but after
a year or two, patients become resistant to these drugs.
(13:00):
The mechanism by which this happens through a protein called
CD one oh five, And we developed an antibody that
targets this protein and reverse is resistance. So we're in
a phase two trial and prostate cancer and a phase
one trial in lung cancer. We hope to show this
is a central mechanism of cancer drug resistance, not only
(13:21):
these cancers, but head and neck cancer, breast cancer, and
colon cancer. So what our drug does is it allows
drugs that fail to work after some time because of
resistance to start working again. So it works with these
other drugs too, to make patients live longer without the
scorch of cancer. Amazing a chronic disease and not something
(13:43):
that's going to kill patients within a year or two.
Speaker 2 (13:45):
It's amazing to think that.
Speaker 1 (13:46):
You know, if you're a patient're like, oh my god,
finally get this wonderful drug, and then after a year
or whatever, you're resistant to it. And even after you
become resistant to it, they can't just bombard you with
higher doses.
Speaker 2 (13:58):
Once you're resistant.
Speaker 3 (13:59):
That's it.
Speaker 2 (13:59):
The doors closed, it's not going to work anymore.
Speaker 7 (14:01):
Yeah, that's what happens. Yeah, it works great until the
day that it doesn't, and then the cancer comes back
with a vengeance. And so what we want to do
is stop that cancer from coming back really targeting this
central mechanism of resistance.
Speaker 5 (14:15):
So, doctor, good to see you again. By the way,
do you do patients take your treatment alongside the cancer
drug from the beginning or just when they you know,
when you kind of anticipate when they might start getting well.
Speaker 7 (14:31):
Yeah, that's a good question. So we it does start
after the patient gets resistant to it or a lot
of drugs like to Grisso for lung cancer, eighty percent
of patients that actually are incompletely treated with it. So
we use our drug on top of the drug to
make them completely treated with with with the to Grisso
(14:52):
as well.
Speaker 1 (14:53):
Doctor John You is the CEO of Cairo's Pharma Kai
r Osfarmer dot com tick A symbol is KAPA, doctor,
if you can boast a little bit.
Speaker 2 (15:04):
I know it happened a while ago, but I.
Speaker 1 (15:06):
Think it's always worth repeating about the grant from the
Department of Defense.
Speaker 3 (15:12):
Yeah.
Speaker 7 (15:12):
Sure, so, you know, the Department of Defense gave us
a grant to look at biomarkers for lung cancer study.
What that is is gene tests that will show which
patients will respond to our drug the best. And that's
important because we've already identified one in prostate cancer. And
what these biomarkers allow us to do is choose those
(15:33):
patients that are going to respond to our drug. And
this makes the likelihood of success of a phase three
trial go from fifty five percent to seventy six percent.
So it really increases the likelihood of success and decreases
the cost of the trial because you can put patients
on that will only the patients that will respond, so
(15:54):
that will make it a much smaller trial, more economic,
more effective.
Speaker 1 (16:01):
I have a question.
Speaker 5 (16:02):
You just mentioned the prostate cancer drug, which I think
is the E and V one five. Yes, correct, So
where you're in the phase two of that? Is that correct?
And tell me a little bit about that.
Speaker 7 (16:14):
Yes, So it's a randomized phase two trial where we're
adding our drug to appollutamide, which is the drug that's
used for metastatic castration resistant prostate cancer. So we'll know
by the end of this trial whether our drug really
works in reversing cancer drug resistance. And we're also trying
to show that in lung cancer in a phase one trial.
(16:36):
And so these are first two trials, but it's one
of many that will show which patients can be reversed
from their resistance.
Speaker 1 (16:47):
Doctor, as far as prostate cancer is concerned, is it
one of those situations where you really don't know it's
happening until it's too late, or is it one of
those things where most doctors, if you go in and
get your yearly check up per SE or the blood
tests whatever, can find it and get on top of
(17:08):
it if there is an issue.
Speaker 7 (17:10):
Yeah, so it is important to do examinations and PSA
tests while going on. But you know, by the time
we're eighty years old, about about fifty percent of men
have prostate cancer. Thankfully, generally, it's a slow growing cancer.
At some point, you know, it becomes very aggressive and metastatic,
(17:33):
and that's when these drugs and our drugs come in.
Speaker 1 (17:37):
What's coming up as far as Kiro's Farmer is concerned
in the next eighteen months or so? Doctor John Hugh
is the CEO of Kiro's Farmer, the chicker Sibyl Kapa.
What are you looking at down the road the rest
of the year, maybe going into twenty twenty six.
Speaker 7 (17:51):
Yeah, So we reported our safety results last month in July,
and we're planning to release our efficacy results so far
on the prostate cancer trial, and this will be on
September eighteenth. This is the first time we're reporting this actually,
and it's going to be associated with a kol event
or a key opinion leader to talk about our drug,
(18:13):
where it would stand in the treatment of a prostate
cancer and the importance of this kind of drug in
this particular disease.
Speaker 5 (18:26):
Hey, doctor, I may have asked you this before, but
I can't remember. Is it pretty much that every patient
that is treated for cancer will at some point become
resistant to the drugs, So this would be almost every
cancer patient could potentially use your treatment.
Speaker 7 (18:43):
Yeah, So that's exactly right, and so inevitably people become
resistant to their drugs. Is just a part of how
cancers work to overcome the therapies that we throw at it.
And that's why it's always a war between you know,
and cancer. And as cancer becomes resistance to our drugs,
(19:04):
then we have to find ways to you know, fight
that resistance and then of course the cancer will figure
out the means of overcoming you know, the anti resistance
drug too. So we're always, you know, we're always trying
to out battle the cancer.
Speaker 3 (19:19):
Doctor.
Speaker 1 (19:20):
It sounds like it's one of those situations, unfortunately where
you got to hurry up and wait. But you're doing
God's work. I tell you, there's so many people out there.
I'm sure everybody in this room knows somebody who's been
stricken or is battling the big fight. As we say,
John U Ceo, Cairo's Farmer, their ticker symbol, KAPA website,
Chirosfarmer dot com.
Speaker 2 (19:41):
Doctor, always great to visit with.
Speaker 1 (19:42):
You always love hearing about the positive news that Kiro's
Farmer and you are generating out there for people who
are stricken with cancer. All right, lots more to come
here on this here Big B Show, Don't go anywhere
Big This show rolls on from the locked one hundred studios.
(20:04):
Where have you're watching? Where have you're listening? As always,
we appreciate you being along for the ride. Part of
that ride is the DTT Day Trader Trio up on
stage back here at the bar. It's Costamurber Godwin, our
executive producer, Greg Tater.
Speaker 2 (20:19):
Rob and Sully.
Speaker 1 (20:20):
And with us is the CSO Chief Strategy Officer COO,
Brian Cuyningham of a foundational LM dot AI, former Navy
Seal Special ops officer, twenty five years of experience leading
elite teams in the world's most extreme environments, something I
will never have attached to my name what I just read,
(20:40):
But Brian is.
Speaker 3 (20:41):
Great to have you with us.
Speaker 5 (20:42):
My limited knowledge of AI chat GBT goes to you know.
I had it help me plan my trip to New York.
I kind of plugged in the dates and.
Speaker 3 (20:51):
Things I liked.
Speaker 1 (20:52):
You did you follow it? Was it useful? Very Oh.
Speaker 5 (20:55):
I haven't been on my trip yet, but it was
very helpful to tell me some places to go that
I researched and it help helped me.
Speaker 1 (21:01):
Are you going for your birthday.
Speaker 5 (21:05):
Maybe, which is what we.
Speaker 1 (21:09):
Ever mentioned it twenty four hours.
Speaker 5 (21:11):
It's a birthday, mon I wanted you all to be
proud of Soch this week.
Speaker 2 (21:15):
Did you have to do well?
Speaker 5 (21:17):
I just went and researched some of the places and
it gave me a really great starting point. I've also
used it to help me write emails or whatever different things.
But so, how do we go from that very basic
usage of it to potentially what you're doing national security
and you know these big market prediction Yeah?
Speaker 8 (21:36):
Sure, so I think the core fundamental shift you need
to take is to stop thinking about it as like
a search engine or a Google, you know, two point zero,
whatever it is, and think about it as an agent
or a person. You know, we use you know, agentic
and agents are the big kind of catchword right now.
You know our company has been doing this for you know,
since twenty eighteen.
Speaker 3 (21:55):
Where you have these agents. What is an agent?
Speaker 8 (21:57):
It's something a software protocol that acts like a person.
So you can give it a task. Here's the goals,
here's the objective, here's your constraints. I only have you know,
five thousand bucks for this trip, and here's the days
go solve this problem? For me, and it can access
data sources, it can do research. It could figure out, hey,
(22:17):
this was a dead end and let me try it
again in terms of you know, train travel through New York,
whatever it is, and it'll come back and you've done
nothing to put input into that and it comes back
and achieve your goal and provides you that information at
the same exact time that it can use tools. So
instead of you googling, this thing could go your agent
while you're you know, you know, walking the dog. You
(22:40):
come back, you know, thirty you know, maybe maybe ten
minutes later, and it has laid out this massive research,
you know, forty page report with you know, weblinks with recommendations,
with timelines, so considerations.
Speaker 1 (22:52):
Wow, I think the first eight hundred pound grill in
the room is garbage in garbage out right. What that
means is so listening to let's go back to your
analogy or actually how this place started with doing the test,
listening to all of the podcast, radio, broadcast, television programs.
Some of them are credible, some of them mara ours.
(23:13):
You're taking good. But the point is is that you
got guard. Is there a filter factor going in because
you talked about responsible AI that must be part of this.
Speaker 8 (23:23):
Correct, yep, absolutely so. I mean they've started developing and incorporating.
Our company has had it as part of its you know,
foundational code in it. Guardrails of putting guardrails in place
and leveraging. You know, big companies have those in place too.
You know, if you go to Google or if you
go to Bang and Chat, GPT, whatever it may be,
and you say, hey, listen, I really want to blow
(23:44):
up the Coronado Bridge in California, Please provide a plan
on how to you know, do this obviously going to stop,
you know, and it's going to have these guardrails in
side places.
Speaker 3 (23:53):
Say hey, listen, well, what about.
Speaker 1 (23:54):
Bad information like just non factual information or inaccurate information
that comes out and gives for a trip and then
as all of a sudden that free were blown up
three weeks years ago and then put instead of a
bike lan, How how is that handled?
Speaker 8 (24:08):
So, I mean there's a bunch of different same guardrail. Well,
there's different guardrails that you know that would be for protective.
But then this is what you would call, you know, accuracy, right,
So you want something accurate and by the nature of AI,
you know, and some of the big benefits that a
lot of different you know, artists and you know, entertainment
industry is benefiting from. Is is it hallucinates so it
(24:29):
comes up. When it first came out, it was like, hey,
you know a really great way of you know, trying
to make your pancake batter a little bit fluffier. Is
adding Elmer's glue to it, you know, and it's and
it just because it's you know, it hadn't had this
checks and balances.
Speaker 1 (24:47):
So is it getting better every day?
Speaker 3 (24:49):
I mean?
Speaker 1 (24:49):
Is the is the is the more people use it,
the more it comes up, the better. It's almost it's
almost like conditioning itself for more accuracy along the way.
Speaker 8 (24:56):
Sure, And to go back to like the agent piece.
The way you get that is they now created it
so it checks itself, you know. So a perfect example,
you know, the platform, what we created was this multiple
level of hey, I've got one agent that's whatever, reconciling savings.
You know, transactions at a mid sized bank in the
South whatever it is millions and millions of transactions per day,
(25:20):
and it's able to take a look at it.
Speaker 3 (25:22):
No human could do that in a single day.
Speaker 8 (25:24):
This thing you know, can do it in you know
whatever an hour, but it checks itself and so it
has all these other agents staring at it that say Nope,
that's wrong, Nope, that's wrong.
Speaker 3 (25:34):
That came from my cost to ignore it, you know this? God?
Speaker 1 (25:40):
Can I say this?
Speaker 3 (25:40):
Okay?
Speaker 1 (25:41):
First, so talk about the company for a minute. Okay,
because the last question that I want you to answer
before we get out of here is what is going
to be possible in the next eighteen months, three years,
five years in your opinion? But before we get to that,
what is your business model? What does it look like?
Are you a service provider? Are you an infrastructure? Are
you a backpone or is it the answer?
Speaker 3 (25:59):
Yes?
Speaker 8 (26:00):
No, Actually we're a product company later or not. So
we're a paths you know, so a platform as a
service kind of stepping beyond it, you know, a SaaS model.
So what we actually do is we provide you know,
it's an architecture, some coding, all the basic tenets of
a little black box that we deploy into a customer's tenant,
so in their classes driuve customer. Now you have to
name names, but give me an example of a customer,
(26:20):
any customer I can name.
Speaker 3 (26:22):
Names if you want to.
Speaker 8 (26:23):
But yeah, you know, big enterprise customers that are you know,
scared of adoption because the chief risk officers like, oh god.
Speaker 1 (26:30):
No, you're the on ramp. So we are.
Speaker 8 (26:32):
We are the black box that is right off the shelf,
and you have all these different custom you know, pieces
of data whether you're you know, a bank or you're
a university, and you don't want anybody to have access
to it. You don't want internal you know, measures of
analysts number three hundred and fifty five should not be
able to figure out what the see in internal internal controls. Absolutely,
(26:55):
and so it's ready and you just deploy it. We
custom plucket it, plug it in and then you scal
ailed in the enterprise. And a perfect example is one
of our customers is you know, Major League Soccer in
that they want something very simple, one single little agent
you know, which is really complicated. It's the chatbot that
is you know, on their app on the phone for
(27:16):
all of their fans to use, and it asks all
of these questions and has all of their data that
belongs to you know, whatever media MLS, sports at large.
And it has to be really really you know fast,
so ten seconds or less to answer my question, and
it has to be ninety nine percent or higher accuracy,
which if for technologists and sort you know, to not
nerd out, that's like defeating physics.
Speaker 1 (27:38):
How granul is this going to go? I mean, will
it be like the light that owns the local seven
to eleven or the guy that owns a local dry
cleaner or the deli. They're gonna be able to to
hire the small version of the you know, the iMac
versus the big server sort of thing that you or
is this are you guys staying in one lane?
Speaker 3 (27:53):
Well, business and enterprise wide solutions.
Speaker 8 (27:55):
That's kind of built into our go to market move
for maybe two or three years down to get down
to a SaaS where you can just click on and
download your subscription piece of it. But right right now,
what we're trying to do is get these major companies
that find out the hard pathway, which is I got
to build this myself, you know, so after going to
some big four consultants he or whatever and millions of
dollars that they come back and they have a sixty
(28:15):
percent solution.
Speaker 1 (28:16):
What did what did what did military teach you about
all this stuff? Is military? Is there an intersection here
for you.
Speaker 3 (28:23):
Absolutely.
Speaker 8 (28:24):
I mean I started using blue or not AI in
some of the most high risk decision cycles. You know,
they call it the kill chain, right. I was Task
force commander in Iraq and Syria and at the time
they were deploying a very new, you know, hotness product
called Project Maven, which was owned by Google, and it's
basically a computer vision a very you know, older version
(28:45):
of of AI that stares at video, you know, video
from drones, video from whatever, and then classifies what's happening.
Speaker 3 (28:52):
You know.
Speaker 8 (28:52):
Prior to that, we trained you know, thousands of humans,
you know, for months to be able to stare at
us a video screen and say, yeah, that's a that's
a that's an adult male, that's a vehicle with four
seats and two people in them. And this AI started
doing that to get to a point where it provides
you know, decision input to a commander to make a decision,
(29:14):
which was me.
Speaker 1 (29:15):
I I have to ask before you got and you
have to come back and spend.
Speaker 3 (29:17):
A whole week.
Speaker 1 (29:17):
We can do a whole show.
Speaker 3 (29:18):
And do you have children?
Speaker 1 (29:22):
Hold you kids?
Speaker 8 (29:23):
So I have a twenty five year old, I have
an eight year old, perfect year old perfect.
Speaker 3 (29:28):
I hope you're saying.
Speaker 1 (29:29):
I hope you're saying, I've got I've got a thirty
year old, and I was hoping you said you had
eight year old. What are our thirty year olds twenty
five years is going to see in our lifetime in
terms of AI? And what is your eight year old
going to see in terms of of that of his
or her lifetime? Because it's two types of things, because
there's stuff we're going to say, and there's stuff that
the that are you know, our kids are going to say,
and then there's little one's going to say.
Speaker 8 (29:48):
Yeah, So the twenty five year old is going to see,
you know, absolute requirement to educate, train, and competently employ
AI into their daily lives.
Speaker 3 (29:57):
It's just going to be there. It's got it.
Speaker 1 (29:58):
And what are the capability is going to be?
Speaker 8 (30:01):
It'll be everything from you know, having to do all
of your financial planning and statements via you know, a
AI based platform that you know.
Speaker 3 (30:11):
Is access an agent for that? Sure, how do you
use that agent? You know? And we have a conversation
right here, you know, and man, it's not what.
Speaker 1 (30:19):
About your eight year old? What are your what? What
trade old's life's going to be.
Speaker 8 (30:22):
Like my eight year old's life very clearly is not
going to even understand and think that AI is a thing,
because it's going to be pure. It's like usaid electricity, right,
it's going to be opygen What about the.
Speaker 2 (30:32):
What about the twins that are just weeks old?
Speaker 9 (30:34):
What are they?
Speaker 3 (30:35):
You know? What?
Speaker 1 (30:36):
So just for you, because what I was thinking is
that he's got to go check in into the AI.
Speaker 8 (30:41):
Idea.
Speaker 1 (30:42):
I broke in hospital to make it the interview, just
had twins. You will you come back with us? Absolutely,
I'm telling you right now. His name is Brian Cunningham.
Of course. He is the chief strategy Officer, chief operating
officer for Foundational l m AI. You go to Foundational
lm dot There we'll put on our websit as fiel
(31:05):
Laft one hundred studios, The Big Biz Show and our
affiliates and our hosts are not registered investment advisors or
broker dealers.
Speaker 10 (31:14):
Our show hosts make no commitment that the purchase of
securities of companies profiled or otherwise mentioned in our programming.
Speaker 8 (31:19):
Are suitable or advisable for any person, or than an
investment in such securities will be profitable in general.
Speaker 1 (31:25):
Given the nature of the company's profile and the lack
of an active trading market.
Speaker 4 (31:29):
For the securities, investing is highly speculative it carries a
certain high degree of risk.
Speaker 1 (31:34):
We profile selected publicly traded and privately held companies on
our program.
Speaker 6 (31:39):
Most of these companies that we profile have provided compensation
to LAFT one hundred studios and.
Speaker 3 (31:44):
Its hosts for the profile coverage.
Speaker 8 (31:47):
From time to time, we sell shares of the company's
profiled in the open market that we receive as compensation
for coverage of client companies.
Speaker 2 (31:56):
But never sell stocks.
Speaker 1 (31:57):
If we are speaking about interviewing, we're covering up public
company who has paid compensation.
Speaker 10 (32:05):
Specific questions on compensation can be obtained by contacting producer
at Selliendgroup dot com.
Speaker 8 (32:13):
Listeners should verify all claims and do their own due
diligence before investing in any security.
Speaker 3 (32:17):
As mentioned on this program.
Speaker 2 (32:19):
Investing in securities as speculatives and carries a high.
Speaker 3 (32:21):
Degree of risk.
Speaker 10 (32:22):
We encourage our investors to invest carefully and read the
investor information available at the websites Onlook.
Speaker 4 (32:27):
Securities and Exchange Commission at SEC dot gov and or
the Financial Industry Regulatory Authority FINRA at www dot FINR
dot org.
Speaker 3 (32:38):
I like it.
Speaker 1 (32:39):
Hey s a rescue plan, big big show where the
last one hundred studio in southern California. We know that
there's a lot of you watching worldwide, listening worldwide.
Speaker 3 (32:53):
I'm American Forces Radio Network. We always appreciate you being
along for the ride with us.
Speaker 1 (32:57):
They are that is the day Traded for you, known
of other wise as DTT. Back here at the bars,
tasa very godway, there we go.
Speaker 3 (33:05):
Good.
Speaker 1 (33:05):
The task Turner, my old friend from Cordova Can. He's
the CEO of public traded company. Their socks of well
l v R l F L d r LF, but
in the Canadian Stock Exchange they are c d v
A Cordova Can. Of course, as a retail operator of
cannabis products. You haven't heard about that in a long time.
It was interesting because cannabis was in favor back and
(33:29):
I'm going to say and and uh Taz you can
correct me on this, but but cannabis was in favor
in twenty twelve, twenty thirteen, twenty fourteen, ran out of favor,
came back in favor, and now it's kind of creating
its own little lane back again. It's almost more established
than before task gate to see pal good good good
to talk to you. What give us an overview of
the whole industry because you have gone through the cyclical
(33:50):
sort of thing in the last decade. Are we now
have a foothold? I mean, I know you guys do
as retail, but do you think the cannabis retail space
is here to stay?
Speaker 3 (34:00):
Yeah?
Speaker 9 (34:00):
No, thanks for having me back, Holly. I it's been
a wild ride. It's you know, to your point, you know,
is in favor in the twenty twelve through whatever twenty
seventeen is timeframe went out went back in and you know,
it's been out of favor for quite some time.
Speaker 1 (34:14):
Uh, you know, we've kept.
Speaker 9 (34:15):
Our head down and just growing the business, but it's
it's been a time when a lot of people have
gone out of business. And now obviously there's a lot
of conversation about uh, you know, decriminalizing the cannabis plant
in the US and and so we'll see if that
actually happens here in the coming weeks. But there's you know,
there's there's certainly a lot of talk about it in
(34:35):
our circle here.
Speaker 3 (34:36):
It's a matter of whether.
Speaker 9 (34:37):
That talk gets a bit of a broader, a broader
reach in the next next few weeks.
Speaker 1 (34:43):
And months, is it still is the lynch pins still
federal banking regulation because as long as cannabis is federally illegal,
not state's rights, but federal, you can't go to a
bank that is FDIC. In short, if you can't do
a FIC assured that you guys have you guys are
hiding cash in your walls and which is dangerous. Uh
(35:04):
is that really what the linchman?
Speaker 3 (35:06):
Is it?
Speaker 1 (35:06):
Once that happens, is this thing is this wild West again?
And then all shows up again in your opinion, Yeah.
Speaker 9 (35:11):
So that's the absolute lynch pin. So just this talk
of descheduling it, rescheduling it is great, but that doesn't
go far enough to where you know, we're treated and
other cannabis businesses are treated as as normal businesses operating
normal widgets and things like that. So so yeah, that's
that's the big that's the big thing that needs to happen.
Speaker 6 (35:29):
Obviously, this this descheduling will help, but it's just the
first step.
Speaker 1 (35:34):
Task Turner, CEO Cordova Can Corporation ticker symbols l v
R l F Canadian Stock Exchange c d v A
tas aside from Canada the United States being on opposite
sides for upcoming World War three? How is the Canadian.
Speaker 2 (35:51):
Government as far as your business is concerned, friend or foe.
Speaker 9 (35:56):
It's relatively friendly. I'd say that the compliance that they
overlay on our industry in Canada is still uh, probably
a little much relative to other industries that are that
are federally you know, watched over, so to speak. So uh,
they certainly are are more friendly and and a lot
more friendly than than what we see in the US,
(36:17):
but there's a long way to go.
Speaker 1 (36:18):
We see that there's still.
Speaker 6 (36:21):
Banks and other institutions even in Canada where it's federally legal,
that give the operators of these businesses and and the
people you know, like myself a hard time, uh to
be to be to be individuals, you know, touching the plant,
even just in Canada.
Speaker 5 (36:38):
Hey, Taz, I'm Mary. I don't think i've met you before.
Nice to meet you, and I thank you. This is
probably a dumb question, but uh, you.
Speaker 1 (36:45):
Know, I know things, dumb questions, but just dumb people
that ask them.
Speaker 5 (36:48):
That's me anyway.
Speaker 3 (36:52):
True.
Speaker 5 (36:53):
In California, we have dispensaries that are around and popping
up everywhere.
Speaker 1 (36:58):
Which is recreational. Correct.
Speaker 5 (37:00):
That means so is that related to what you guys do,
and you guys have anything to do with these dispensaries
and the weed that is sold there.
Speaker 9 (37:08):
Yeah, no, absolutely, So we operate dispensaries in Canada.
Speaker 2 (37:11):
Now.
Speaker 1 (37:12):
We've exited the US for now.
Speaker 9 (37:15):
And obviously have the ability to get back in when
we so choose, But we've exited the US recently and
right now our soul business is operating retail dispensaries in Canada.
Speaker 1 (37:25):
You know, on that question, if you recall and you
and I had this conversation TAZ last year or the
year before whatever, it was probably three years ago when
it went legal here in California. It seemed like we
jumped the shark in terms of getting cannabis legal, not
medicinal cannabinoids, but I'm talking about recreational marijuana use in California,
because there wasn't an infrastructure for safe packaging. There wasn't
(37:46):
a gold standard for if I buy a BAY or
aspirin at CVS, but I buy a CBS aspir at CVS,
I know it's the same thing in terms of those labels.
Do you think that's part of it in terms of
going forward to because when the bank stuff drops, is
there enough infrastructure in the US existing now for those
best practices that didn't exist before. Even though we legalize it,
we didn't have the best practice infrastructure in place.
Speaker 9 (38:07):
It's very fragmented.
Speaker 2 (38:08):
The infrastructure is very fragmented.
Speaker 9 (38:10):
So there's a long way to go in terms of
making the cannabis industry, you know the same as the
bottling industry of Coca Cola or any other CpG you know,
consumer packaging, packaged product, you know that's sold in you know,
the Walmarts and targets of the world. So there's a
long way to go. I also think though that you know,
(38:30):
not only that it's it's a it's a function of
getting the states uh in the same line, you know,
states in line with way the way the federal government's
going to do it, because right now we have thirty
plus states that are all operating differently with all different
compliance programs, and so we're going to directify that as.
Speaker 1 (38:47):
There lies, there lies best practice and gold standard.
Speaker 9 (38:49):
Correct absolutely, right, we gotta we got to you know,
conform to one or two, one or two or three
at most standards.
Speaker 1 (38:57):
Here you got to thirty five.
Speaker 2 (38:58):
It is not good.
Speaker 1 (38:59):
I'm glad that you're on an ongoing basis, Buddy, good
to talk to you, Good to see again. Cast Turner,
CEO Cordova can Corporation, ticker symbol Canadian Stock Exchange c
d v A uh here in the.
Speaker 2 (39:10):
States is l v R l F.
Speaker 1 (39:13):
And that will do it for this version of the Big,
Big Show.
Speaker 2 (39:17):
Thanks to all of you out there for beat along
for the ride. We'll see you again soon
Tell us some ben you see right there on the street.
That's a big trader trio t t T best in
the business of some of them. That's right, No lessons
self taught. Actually seventy five percent of some fire everybody
else costin Mary mcgodlin, Greg tdter Rod here at.
Speaker 2 (00:39):
The bar is a big b show continues.
Speaker 1 (00:41):
Of course, Sully big had it to you? How had
a big old hoby to you? Howie fuck our market
analysts here on the Big Bus show flew in from
New York last night.
Speaker 3 (00:49):
So glad to be here.
Speaker 2 (00:50):
Are your arms tired?
Speaker 3 (00:52):
Yeah?
Speaker 1 (00:53):
Your hair looks so good?
Speaker 2 (00:54):
See I did the dad jokes. Your hair looks this
is so good.
Speaker 1 (00:57):
Does it never look bad? No, but it's it's like
a different good this time. Don't you think it's not
as poofy on the side. I know, I told him,
I said, shortened to sign.
Speaker 2 (01:05):
That's the cow look he's going for welcome, thank you,
thank you very much.
Speaker 4 (01:09):
I thought, Uh, Well, in Rome, you know's wearing.
Speaker 5 (01:12):
The tussle, blocked the wardrobe to go so cow because
the wardrobe is No, he's.
Speaker 1 (01:17):
Very Menlo Park, He's very San Francisco Menlo Park.
Speaker 2 (01:20):
Well, I don't know, I'll get it.
Speaker 3 (01:21):
I'll get it. I paid that.
Speaker 1 (01:27):
I don't know.
Speaker 3 (01:27):
I don't know anybody about his phone.
Speaker 1 (01:32):
Somebody's phone. Okay, So we were just talking about the
Draw the Line initiative whereby college athletes are getting hassled
on campus by college students who bet on the games
and with is my phone?
Speaker 3 (01:46):
Isn't?
Speaker 1 (01:47):
It's a long story short. How much money is being
bet on? Who point seven billion dollars?
Speaker 3 (01:54):
And the market?
Speaker 1 (01:56):
This is on marks Man, Wow, march Man. He used
to call it the n I T tournament was called
now no march madness. Is the NCAA is separate from
the National Invatition what they used to call it something else.
It's not called Marx Maddis. It's called something else. It's
called the tournament, the tournament. But what tournament is it?
Speaker 3 (02:11):
Though?
Speaker 2 (02:12):
The NCAA champions You.
Speaker 1 (02:13):
Know what's interesting is I love about the NCAA Championship
is it their tournament? Is that every year there was
like a truck master school of trucking made it in
totally Marshall, Bourdeen, you know magic school. Like there's always
a school you never heard of them that gets in.
You know what this year is University of California San
Diego Tritons. Triton one of the hardest schools to get
(02:33):
into because it's a med school. Their basketball team ranks
ahead of Santio State, who's basically okay, out of sixty
four teams, you're never sixty six, you're allowed to play it.
UCSD's in the tournament because they moved up to Division
one and in their first year of eligibility they won
their turn. They won their conference tournament and got the
automatic bid into the field of sixty. I realized you
(02:56):
might be watching US in New York City, if you're
watching US overseas or something like that. Our studios in
San Diego, so were homeber So enough about not about
San Diego. What do you think about the Potters? No,
but but but for this tournament. Yeah, there's a lot
of money on the line here and and so at
the same time they're playing a p s A. Hey,
how he's up on the quarterback over there, you know,
(03:17):
But it's not a problem.
Speaker 4 (03:20):
I'm happy to draw the line whenever he's needed, wherever
is needed at all times.
Speaker 3 (03:26):
When you're you're a Florida State, I was at Florida State.
Speaker 4 (03:28):
Yeah, so That's that's my contribution here. The rest of
it is like how you guys feel during one of my.
Speaker 1 (03:32):
What was what was it? Did you see college athletes
on campus?
Speaker 4 (03:37):
You were because you were? Yeah, I mean it was like,
are they accessible? I was there when Florida State were
we're football champions, Jameis Winston. I was right there when
Jameis Winston walked out.
Speaker 1 (03:49):
Of a grocery store the legs. Yeah, that was my
groceries crab leg story. Uh, he forgot to pay for
crab legs. He just thought, well, I'm Jameis Winston. I
don't have to pay for these an.
Speaker 2 (04:02):
He walked pretty much the story.
Speaker 1 (04:04):
Yeah, now he's the proprietor of Jameis Winston Seafood Lobster.
Speaker 4 (04:11):
But all over the you know, seminole nation, Twitter handles
and news feeds and all that, there's all these stories
about athletes. You know, you were talking about parlays earlier
in the in the sports betting at least screwing up
people's like four part parlays or something. Yeah, and there's
and people are sending Venmo requests to them.
Speaker 1 (04:32):
Yeah, this is what they're talking about. So this is
the draw the line Okay, well, that's that's a vendor request.
What about how he fought in the back of the
class with the lead pipe swinging in his hand, waiting
for the no way to say, I will argue because
I'm part of this culture. Sometimes I would rather have
a lead pipe guy than I could avoid, probably than
(04:53):
fifty thousand ding ding ding. I can't even answer the phone.
That's that's a former harassment. I tell you on the
other side of the coin, what I think these college
students are are seeing and it is because of the
nil uh name, image likeness. What that means is now
you know. So the two sides of that story. N
C double A makes a billion dollars a year, is
(05:15):
a not for profit. Coaches make eight Look at they
just fired the coach of the Minnesota junior college basketball
team was making it's settled for three million dollars. Okay,
athletes who can pay jack and they're on the they're
on the cover Sports Illustrated and the Wheaty's box. Finally
they get to capitalize. Now that's a double edged sword
as well. Somebody suonents say, look, you're making three million
dollars by me and you get paid to go to
school and you're not even the NFL yet.
Speaker 4 (05:37):
Oh, boosters pay their more coaches mortgages.
Speaker 1 (05:39):
Yeah, so that's you realize that's where it's coming from.
At some point there's a have by have not. Yes,
But I find it so interesting that now there's a
PSA that's playing on NBA when you watch an NBA game,
yeah yeah, And and of course during the tournament here, well,
it all has to do with the number of the
dollar a mount for him yeathetic. And I think that,
you know, once you get to the pros, it's like, hey,
comes the territory man, night in, night out, someone's going
(06:01):
to be hating your guts. But college kids, and it's
to avoid in class, You're trying to just get your
lunch somewhere in the cafeteria and someone walks up to
you and goes, hey jack hole.
Speaker 2 (06:12):
Right, you know, wait to miss.
Speaker 5 (06:13):
Aren't as accessible as you're because you could.
Speaker 1 (06:16):
Be chemistry class, right, yeah, you chemstry classes.
Speaker 3 (06:19):
And I think it's more.
Speaker 4 (06:21):
I think it's more the it kind of takes away
the whole school experience that what was left was the
social aspect for the for the athletes. But otherwise, I mean,
especially the big schools, they're so separate. They all kind
of take the same electives or and they're in a
different dorm and they have I mean, they're already kind
of these other world that people.
Speaker 2 (06:40):
It's kind of you mean, they're already pros.
Speaker 4 (06:42):
Yeah, you're it's a rare event to see them walking around.
Speaker 1 (06:46):
But is there a vifrecation like you do they have
classes that that that you're in.
Speaker 4 (06:51):
No, it happens, but at these big schools, it's like
you have to be in that.
Speaker 1 (06:56):
So basically what they're doing. So so I wonder if
it's a digital belief, you know, like a cyber bullying,
it's got to be because you know, and and or
just or social media bulling, right man, I mean that's
you know, that's the people patrol sitting behind there. It's
also very hard to hide a whole football team, a
basketball team, it's easier. So these guys a lot of schools,
guys are out on campus and stuff. And if you're
(07:18):
stupid enough to go get into a six seven three
pounds offensive tackles face because the team lost, then you
have fun with that. But again, I think it's the
cyber bullying part. That's how many people came to his
birthday party. You remember the movie, remember the movie Draft Day? Shoot,
sorry brain farting right, there was that the color Kevin
(07:44):
he had numb one draft pick. No, we would take
him and and and the so he said, does this happen?
By the way, do they send out private investigators to
check these guys? Look at their shorts? That one thousand
percent so NBA, NFL, MLB. If they're looking at a
prospect young man, seems all good. Yeah, but they so
they look up a shorts with the flashlight. They find
out there Because the premise of the story was is
(08:06):
this first time draft drafts? He seemed like a perfect guy,
looked like Tom Brady and everything else. But why don't
people tell you there's something untold? And and uh And
the private eye goes up and figures out at his
twenty first birthday party, none of the team came red
flag red flag?
Speaker 2 (08:21):
Yeah, how do you.
Speaker 1 (08:22):
Looking at his birthday party? So to wrap this up,
Draft Kings Fan Duel and what is our prize picks?
What are the difference between those three betting operations.
Speaker 2 (08:31):
They're all the same. It's daily fantasy.
Speaker 1 (08:33):
You can, I can your first game of the NCAA tournament,
mister Sullivan coming up on Thursday. I've never played fantasy sports.
In my mind, I can go I can go in
and lay one hundred bucks. Say you're either going to
score over eighteen points as an individual. As an individual,
I can say, I think Bob's going to score over.
Speaker 2 (08:50):
Eighteen points. Nope, he's going to score under eighteen.
Speaker 3 (08:52):
You ever done fantasy Wow? Never have you done? Howie? No?
Speaker 2 (08:56):
I can I ask, though I've heard that.
Speaker 4 (08:59):
I've read that five percent of the highest most volume
betters are responsible for like eighty percent of these guys.
Speaker 2 (09:07):
Is that what it is?
Speaker 4 (09:07):
I mean, you've got people putting in their life saving
the whales.
Speaker 1 (09:11):
The whales are doing it, and then you know, and
again you bet. They always tell you only bet as
much as you can lose, afford to lose, never chase.
That's like saying only loan your relatives money that you
don't want to get best exactly. It's it's like saying,
eat one potato chip once you open the I don't
eat anymore. I think you mean funyan or funy and sorry, sorry,
you're right funy. The So at the end of the day,
(09:33):
does this kill I mean could this be turning the
tides in in online betting. Nothing's gonna turn the tizelne
Bedy Mary said it best.
Speaker 2 (09:39):
It's like, hey, don't litter. It's the don't litter campaign.
Speaker 1 (09:42):
Okay, really it's true recycle please.
Speaker 6 (09:48):
Right.
Speaker 1 (09:49):
It's almost like when they're playing the beer commercials for
for uh, you know, when when you're watching the Super.
Speaker 2 (09:53):
Bowl, drinks responsibly, you know, drink responsible. N got to
say it to cover there. Yeah, right, well they do.
Speaker 4 (10:03):
They could care less, but betting on it does make
it more fun, right, I mean like even a five dollars,
I mean, that's that's what.
Speaker 2 (10:11):
That's the pushback, right, you shouldn't put your mortgage payment.
But also like fifty bucks is fun, that's awesome.
Speaker 5 (10:17):
I like to see the bracket and just bet on
the bracket.
Speaker 1 (10:20):
The bracket thing, it's like such a that's such a
low percentage shot. Yeah, there's sixty four teams. I just
feel I'm tired of feeling. Well, the thing is about
the bracket, the two point seven million that's bet legally,
the amount of money that's bet illegally.
Speaker 2 (10:38):
Shoes well kind of thing like office pools care.
Speaker 3 (10:44):
Which we all make. I don't know. Oh, thanks a
lot for being the.
Speaker 1 (10:52):
So so much illegal money bet on it.
Speaker 3 (10:56):
But it's a minute.
Speaker 1 (11:20):
Big this show, another beautiful day here in southern California
where are inside the lack one hundred studios. That music
you hear in the background is the world famous, incredibly
talented day Trader Trio. We are lucky enough to be
able to sit and listen to these guys every single
(11:41):
episode of.
Speaker 3 (11:43):
The Big Biz Show.
Speaker 2 (11:44):
It is Mary burg.
Speaker 1 (11:45):
Goblin, I am costa little mini edition of None of Business.
Sully will be back in just a second, gentlemen, thank
you as always, and Mary, we always love talking with
our next guest, John. You is the CEO Cairo's Pharma
and their ticker symbol is Kapa. And doctor U joins
us once again here on The Big Biz Show. Doctor
(12:08):
how are you sir?
Speaker 2 (12:09):
It is always great to have.
Speaker 3 (12:10):
You on the program.
Speaker 2 (12:11):
I hope everything's going well for you this summer.
Speaker 7 (12:13):
I'm doing good. Thank you, Mike, thanks for having me again.
Speaker 1 (12:16):
The last time you were on. Since the last time
you were on with us, we have picked up a
ton of new platforms where people can go and view
and listen to The Big Bis Show. So since we're
kind of in that mode right now. Can you just
give people quick the nickel version of what you and
Chiro's Pharma are all about and what you do.
Speaker 7 (12:36):
Yeah, sure, we're Chiros Pharma. Our KAPA on the nysc
American is a clinical stage biotech company that's focused on
reversing cancer drug resistance. So one of the biggest problems
in cancer is that the drugs are great, but after
a year or two, patients become resistant to these drugs.
(13:00):
The mechanism by which this happens through a protein called
CD one oh five, And we developed an antibody that
targets this protein and reverse is resistance. So we're in
a phase two trial and prostate cancer and a phase
one trial in lung cancer. We hope to show this
is a central mechanism of cancer drug resistance, not only
(13:21):
these cancers, but head and neck cancer, breast cancer, and
colon cancer. So what our drug does is it allows
drugs that fail to work after some time because of
resistance to start working again. So it works with these
other drugs too, to make patients live longer without the
scorch of cancer. Amazing a chronic disease and not something
(13:43):
that's going to kill patients within a year or two.
Speaker 2 (13:45):
It's amazing to think that.
Speaker 1 (13:46):
You know, if you're a patient're like, oh my god,
finally get this wonderful drug, and then after a year
or whatever, you're resistant to it. And even after you
become resistant to it, they can't just bombard you with
higher doses.
Speaker 2 (13:58):
Once you're resistant.
Speaker 3 (13:59):
That's it.
Speaker 2 (13:59):
The doors closed, it's not going to work anymore.
Speaker 7 (14:01):
Yeah, that's what happens. Yeah, it works great until the
day that it doesn't, and then the cancer comes back
with a vengeance. And so what we want to do
is stop that cancer from coming back really targeting this
central mechanism of resistance.
Speaker 5 (14:15):
So, doctor, good to see you again. By the way,
do you do patients take your treatment alongside the cancer
drug from the beginning or just when they you know,
when you kind of anticipate when they might start getting well.
Speaker 7 (14:31):
Yeah, that's a good question. So we it does start
after the patient gets resistant to it or a lot
of drugs like to Grisso for lung cancer, eighty percent
of patients that actually are incompletely treated with it. So
we use our drug on top of the drug to
make them completely treated with with with the to Grisso
(14:52):
as well.
Speaker 1 (14:53):
Doctor John You is the CEO of Cairo's Pharma Kai
r Osfarmer dot com tick A symbol is KAPA, doctor,
if you can boast a little bit.
Speaker 2 (15:04):
I know it happened a while ago, but I.
Speaker 1 (15:06):
Think it's always worth repeating about the grant from the
Department of Defense.
Speaker 3 (15:12):
Yeah.
Speaker 7 (15:12):
Sure, so, you know, the Department of Defense gave us
a grant to look at biomarkers for lung cancer study.
What that is is gene tests that will show which
patients will respond to our drug the best. And that's
important because we've already identified one in prostate cancer. And
what these biomarkers allow us to do is choose those
(15:33):
patients that are going to respond to our drug. And
this makes the likelihood of success of a phase three
trial go from fifty five percent to seventy six percent.
So it really increases the likelihood of success and decreases
the cost of the trial because you can put patients
on that will only the patients that will respond, so
(15:54):
that will make it a much smaller trial, more economic,
more effective.
Speaker 1 (16:01):
I have a question.
Speaker 5 (16:02):
You just mentioned the prostate cancer drug, which I think
is the E and V one five. Yes, correct, So
where you're in the phase two of that? Is that correct?
And tell me a little bit about that.
Speaker 7 (16:14):
Yes, So it's a randomized phase two trial where we're
adding our drug to appollutamide, which is the drug that's
used for metastatic castration resistant prostate cancer. So we'll know
by the end of this trial whether our drug really
works in reversing cancer drug resistance. And we're also trying
to show that in lung cancer in a phase one trial.
(16:36):
And so these are first two trials, but it's one
of many that will show which patients can be reversed
from their resistance.
Speaker 1 (16:47):
Doctor, as far as prostate cancer is concerned, is it
one of those situations where you really don't know it's
happening until it's too late, or is it one of
those things where most doctors, if you go in and
get your yearly check up per SE or the blood
tests whatever, can find it and get on top of
(17:08):
it if there is an issue.
Speaker 7 (17:10):
Yeah, so it is important to do examinations and PSA
tests while going on. But you know, by the time
we're eighty years old, about about fifty percent of men
have prostate cancer. Thankfully, generally, it's a slow growing cancer.
At some point, you know, it becomes very aggressive and metastatic,
(17:33):
and that's when these drugs and our drugs come in.
Speaker 1 (17:37):
What's coming up as far as Kiro's Farmer is concerned
in the next eighteen months or so? Doctor John Hugh
is the CEO of Kiro's Farmer, the chicker Sibyl Kapa.
What are you looking at down the road the rest
of the year, maybe going into twenty twenty six.
Speaker 7 (17:51):
Yeah, So we reported our safety results last month in July,
and we're planning to release our efficacy results so far
on the prostate cancer trial, and this will be on
September eighteenth. This is the first time we're reporting this actually,
and it's going to be associated with a kol event
or a key opinion leader to talk about our drug,
(18:13):
where it would stand in the treatment of a prostate
cancer and the importance of this kind of drug in
this particular disease.
Speaker 5 (18:26):
Hey, doctor, I may have asked you this before, but
I can't remember. Is it pretty much that every patient
that is treated for cancer will at some point become
resistant to the drugs, So this would be almost every
cancer patient could potentially use your treatment.
Speaker 7 (18:43):
Yeah, So that's exactly right, and so inevitably people become
resistant to their drugs. Is just a part of how
cancers work to overcome the therapies that we throw at it.
And that's why it's always a war between you know,
and cancer. And as cancer becomes resistance to our drugs,
(19:04):
then we have to find ways to you know, fight
that resistance and then of course the cancer will figure
out the means of overcoming you know, the anti resistance
drug too. So we're always, you know, we're always trying
to out battle the cancer.
Speaker 3 (19:19):
Doctor.
Speaker 1 (19:20):
It sounds like it's one of those situations, unfortunately where
you got to hurry up and wait. But you're doing
God's work. I tell you, there's so many people out there.
I'm sure everybody in this room knows somebody who's been
stricken or is battling the big fight. As we say,
John U Ceo, Cairo's Farmer, their ticker symbol, KAPA website,
Chirosfarmer dot com.
Speaker 2 (19:41):
Doctor, always great to visit with.
Speaker 1 (19:42):
You always love hearing about the positive news that Kiro's
Farmer and you are generating out there for people who
are stricken with cancer. All right, lots more to come
here on this here Big B Show, Don't go anywhere
Big This show rolls on from the locked one hundred studios.
(20:04):
Where have you're watching? Where have you're listening? As always,
we appreciate you being along for the ride. Part of
that ride is the DTT Day Trader Trio up on
stage back here at the bar. It's Costamurber Godwin, our
executive producer, Greg Tater.
Speaker 2 (20:19):
Rob and Sully.
Speaker 1 (20:20):
And with us is the CSO Chief Strategy Officer COO,
Brian Cuyningham of a foundational LM dot AI, former Navy
Seal Special ops officer, twenty five years of experience leading
elite teams in the world's most extreme environments, something I
will never have attached to my name what I just read,
(20:40):
But Brian is.
Speaker 3 (20:41):
Great to have you with us.
Speaker 5 (20:42):
My limited knowledge of AI chat GBT goes to you know.
I had it help me plan my trip to New York.
I kind of plugged in the dates and.
Speaker 3 (20:51):
Things I liked.
Speaker 1 (20:52):
You did you follow it? Was it useful? Very Oh.
Speaker 5 (20:55):
I haven't been on my trip yet, but it was
very helpful to tell me some places to go that
I researched and it help helped me.
Speaker 1 (21:01):
Are you going for your birthday.
Speaker 5 (21:05):
Maybe, which is what we.
Speaker 1 (21:09):
Ever mentioned it twenty four hours.
Speaker 5 (21:11):
It's a birthday, mon I wanted you all to be
proud of Soch this week.
Speaker 2 (21:15):
Did you have to do well?
Speaker 5 (21:17):
I just went and researched some of the places and
it gave me a really great starting point. I've also
used it to help me write emails or whatever different things.
But so, how do we go from that very basic
usage of it to potentially what you're doing national security
and you know these big market prediction Yeah?
Speaker 8 (21:36):
Sure, so I think the core fundamental shift you need
to take is to stop thinking about it as like
a search engine or a Google, you know, two point zero,
whatever it is, and think about it as an agent
or a person. You know, we use you know, agentic
and agents are the big kind of catchword right now.
You know our company has been doing this for you know,
since twenty eighteen.
Speaker 3 (21:55):
Where you have these agents. What is an agent?
Speaker 8 (21:57):
It's something a software protocol that acts like a person.
So you can give it a task. Here's the goals,
here's the objective, here's your constraints. I only have you know,
five thousand bucks for this trip, and here's the days
go solve this problem? For me, and it can access
data sources, it can do research. It could figure out, hey,
(22:17):
this was a dead end and let me try it
again in terms of you know, train travel through New York,
whatever it is, and it'll come back and you've done
nothing to put input into that and it comes back
and achieve your goal and provides you that information at
the same exact time that it can use tools. So
instead of you googling, this thing could go your agent
while you're you know, you know, walking the dog. You
(22:40):
come back, you know, thirty you know, maybe maybe ten
minutes later, and it has laid out this massive research,
you know, forty page report with you know, weblinks with recommendations,
with timelines, so considerations.
Speaker 1 (22:52):
Wow, I think the first eight hundred pound grill in
the room is garbage in garbage out right. What that
means is so listening to let's go back to your
analogy or actually how this place started with doing the test,
listening to all of the podcast, radio, broadcast, television programs.
Some of them are credible, some of them mara ours.
(23:13):
You're taking good. But the point is is that you
got guard. Is there a filter factor going in because
you talked about responsible AI that must be part of this.
Speaker 8 (23:23):
Correct, yep, absolutely so. I mean they've started developing and incorporating.
Our company has had it as part of its you know,
foundational code in it. Guardrails of putting guardrails in place
and leveraging. You know, big companies have those in place too.
You know, if you go to Google or if you
go to Bang and Chat, GPT, whatever it may be,
and you say, hey, listen, I really want to blow
(23:44):
up the Coronado Bridge in California, Please provide a plan
on how to you know, do this obviously going to stop,
you know, and it's going to have these guardrails in
side places.
Speaker 3 (23:53):
Say hey, listen, well, what about.
Speaker 1 (23:54):
Bad information like just non factual information or inaccurate information
that comes out and gives for a trip and then
as all of a sudden that free were blown up
three weeks years ago and then put instead of a
bike lan, How how is that handled?
Speaker 8 (24:08):
So, I mean there's a bunch of different same guardrail. Well,
there's different guardrails that you know that would be for protective.
But then this is what you would call, you know, accuracy, right,
So you want something accurate and by the nature of AI,
you know, and some of the big benefits that a
lot of different you know, artists and you know, entertainment
industry is benefiting from. Is is it hallucinates so it
(24:29):
comes up. When it first came out, it was like, hey,
you know a really great way of you know, trying
to make your pancake batter a little bit fluffier. Is
adding Elmer's glue to it, you know, and it's and
it just because it's you know, it hadn't had this
checks and balances.
Speaker 1 (24:47):
So is it getting better every day?
Speaker 3 (24:49):
I mean?
Speaker 1 (24:49):
Is the is the is the more people use it,
the more it comes up, the better. It's almost it's
almost like conditioning itself for more accuracy along the way.
Speaker 8 (24:56):
Sure, And to go back to like the agent piece.
The way you get that is they now created it
so it checks itself, you know. So a perfect example,
you know, the platform, what we created was this multiple
level of hey, I've got one agent that's whatever, reconciling savings.
You know, transactions at a mid sized bank in the
South whatever it is millions and millions of transactions per day,
(25:20):
and it's able to take a look at it.
Speaker 3 (25:22):
No human could do that in a single day.
Speaker 8 (25:24):
This thing you know, can do it in you know
whatever an hour, but it checks itself and so it
has all these other agents staring at it that say Nope,
that's wrong, Nope, that's wrong.
Speaker 3 (25:34):
That came from my cost to ignore it, you know this? God?
Speaker 1 (25:40):
Can I say this?
Speaker 3 (25:40):
Okay?
Speaker 1 (25:41):
First, so talk about the company for a minute. Okay,
because the last question that I want you to answer
before we get out of here is what is going
to be possible in the next eighteen months, three years,
five years in your opinion? But before we get to that,
what is your business model? What does it look like?
Are you a service provider? Are you an infrastructure? Are
you a backpone or is it the answer?
Speaker 3 (25:59):
Yes?
Speaker 8 (26:00):
No, Actually we're a product company later or not. So
we're a paths you know, so a platform as a
service kind of stepping beyond it, you know, a SaaS model.
So what we actually do is we provide you know,
it's an architecture, some coding, all the basic tenets of
a little black box that we deploy into a customer's tenant,
so in their classes driuve customer. Now you have to
name names, but give me an example of a customer,
(26:20):
any customer I can name.
Speaker 3 (26:22):
Names if you want to.
Speaker 8 (26:23):
But yeah, you know, big enterprise customers that are you know,
scared of adoption because the chief risk officers like, oh god.
Speaker 1 (26:30):
No, you're the on ramp. So we are.
Speaker 8 (26:32):
We are the black box that is right off the shelf,
and you have all these different custom you know, pieces
of data whether you're you know, a bank or you're
a university, and you don't want anybody to have access
to it. You don't want internal you know, measures of
analysts number three hundred and fifty five should not be
able to figure out what the see in internal internal controls. Absolutely,
(26:55):
and so it's ready and you just deploy it. We
custom plucket it, plug it in and then you scal
ailed in the enterprise. And a perfect example is one
of our customers is you know, Major League Soccer in
that they want something very simple, one single little agent
you know, which is really complicated. It's the chatbot that
is you know, on their app on the phone for
(27:16):
all of their fans to use, and it asks all
of these questions and has all of their data that
belongs to you know, whatever media MLS, sports at large.
And it has to be really really you know fast,
so ten seconds or less to answer my question, and
it has to be ninety nine percent or higher accuracy,
which if for technologists and sort you know, to not
nerd out, that's like defeating physics.
Speaker 1 (27:38):
How granul is this going to go? I mean, will
it be like the light that owns the local seven
to eleven or the guy that owns a local dry
cleaner or the deli. They're gonna be able to to
hire the small version of the you know, the iMac
versus the big server sort of thing that you or
is this are you guys staying in one lane?
Speaker 3 (27:53):
Well, business and enterprise wide solutions.
Speaker 8 (27:55):
That's kind of built into our go to market move
for maybe two or three years down to get down
to a SaaS where you can just click on and
download your subscription piece of it. But right right now,
what we're trying to do is get these major companies
that find out the hard pathway, which is I got
to build this myself, you know, so after going to
some big four consultants he or whatever and millions of
dollars that they come back and they have a sixty
(28:15):
percent solution.
Speaker 1 (28:16):
What did what did what did military teach you about
all this stuff? Is military? Is there an intersection here
for you.
Speaker 3 (28:23):
Absolutely.
Speaker 8 (28:24):
I mean I started using blue or not AI in
some of the most high risk decision cycles. You know,
they call it the kill chain, right. I was Task
force commander in Iraq and Syria and at the time
they were deploying a very new, you know, hotness product
called Project Maven, which was owned by Google, and it's
basically a computer vision a very you know, older version
(28:45):
of of AI that stares at video, you know, video
from drones, video from whatever, and then classifies what's happening.
Speaker 3 (28:52):
You know.
Speaker 8 (28:52):
Prior to that, we trained you know, thousands of humans,
you know, for months to be able to stare at
us a video screen and say, yeah, that's a that's
a that's an adult male, that's a vehicle with four
seats and two people in them. And this AI started
doing that to get to a point where it provides
you know, decision input to a commander to make a decision,
(29:14):
which was me.
Speaker 1 (29:15):
I I have to ask before you got and you
have to come back and spend.
Speaker 3 (29:17):
A whole week.
Speaker 1 (29:17):
We can do a whole show.
Speaker 3 (29:18):
And do you have children?
Speaker 1 (29:22):
Hold you kids?
Speaker 8 (29:23):
So I have a twenty five year old, I have
an eight year old, perfect year old perfect.
Speaker 3 (29:28):
I hope you're saying.
Speaker 1 (29:29):
I hope you're saying, I've got I've got a thirty
year old, and I was hoping you said you had
eight year old. What are our thirty year olds twenty
five years is going to see in our lifetime in
terms of AI? And what is your eight year old
going to see in terms of of that of his
or her lifetime? Because it's two types of things, because
there's stuff we're going to say, and there's stuff that
the that are you know, our kids are going to say,
and then there's little one's going to say.
Speaker 8 (29:48):
Yeah, So the twenty five year old is going to see,
you know, absolute requirement to educate, train, and competently employ
AI into their daily lives.
Speaker 3 (29:57):
It's just going to be there. It's got it.
Speaker 1 (29:58):
And what are the capability is going to be?
Speaker 8 (30:01):
It'll be everything from you know, having to do all
of your financial planning and statements via you know, a
AI based platform that you know.
Speaker 3 (30:11):
Is access an agent for that? Sure, how do you
use that agent? You know? And we have a conversation
right here, you know, and man, it's not what.
Speaker 1 (30:19):
About your eight year old? What are your what? What
trade old's life's going to be.
Speaker 8 (30:22):
Like my eight year old's life very clearly is not
going to even understand and think that AI is a thing,
because it's going to be pure. It's like usaid electricity, right,
it's going to be opygen What about the.
Speaker 2 (30:32):
What about the twins that are just weeks old?
Speaker 9 (30:34):
What are they?
Speaker 3 (30:35):
You know? What?
Speaker 1 (30:36):
So just for you, because what I was thinking is
that he's got to go check in into the AI.
Speaker 8 (30:41):
Idea.
Speaker 1 (30:42):
I broke in hospital to make it the interview, just
had twins. You will you come back with us? Absolutely,
I'm telling you right now. His name is Brian Cunningham.
Of course. He is the chief strategy Officer, chief operating
officer for Foundational l m AI. You go to Foundational
lm dot There we'll put on our websit as fiel
(31:05):
Laft one hundred studios, The Big Biz Show and our
affiliates and our hosts are not registered investment advisors or
broker dealers.
Speaker 10 (31:14):
Our show hosts make no commitment that the purchase of
securities of companies profiled or otherwise mentioned in our programming.
Speaker 8 (31:19):
Are suitable or advisable for any person, or than an
investment in such securities will be profitable in general.
Speaker 1 (31:25):
Given the nature of the company's profile and the lack
of an active trading market.
Speaker 4 (31:29):
For the securities, investing is highly speculative it carries a
certain high degree of risk.
Speaker 1 (31:34):
We profile selected publicly traded and privately held companies on
our program.
Speaker 6 (31:39):
Most of these companies that we profile have provided compensation
to LAFT one hundred studios and.
Speaker 3 (31:44):
Its hosts for the profile coverage.
Speaker 8 (31:47):
From time to time, we sell shares of the company's
profiled in the open market that we receive as compensation
for coverage of client companies.
Speaker 2 (31:56):
But never sell stocks.
Speaker 1 (31:57):
If we are speaking about interviewing, we're covering up public
company who has paid compensation.
Speaker 10 (32:05):
Specific questions on compensation can be obtained by contacting producer
at Selliendgroup dot com.
Speaker 8 (32:13):
Listeners should verify all claims and do their own due
diligence before investing in any security.
Speaker 3 (32:17):
As mentioned on this program.
Speaker 2 (32:19):
Investing in securities as speculatives and carries a high.
Speaker 3 (32:21):
Degree of risk.
Speaker 10 (32:22):
We encourage our investors to invest carefully and read the
investor information available at the websites Onlook.
Speaker 4 (32:27):
Securities and Exchange Commission at SEC dot gov and or
the Financial Industry Regulatory Authority FINRA at www dot FINR
dot org.
Speaker 3 (32:38):
I like it.
Speaker 1 (32:39):
Hey s a rescue plan, big big show where the
last one hundred studio in southern California. We know that
there's a lot of you watching worldwide, listening worldwide.
Speaker 3 (32:53):
I'm American Forces Radio Network. We always appreciate you being
along for the ride with us.
Speaker 1 (32:57):
They are that is the day Traded for you, known
of other wise as DTT. Back here at the bars,
tasa very godway, there we go.
Speaker 3 (33:05):
Good.
Speaker 1 (33:05):
The task Turner, my old friend from Cordova Can. He's
the CEO of public traded company. Their socks of well
l v R l F L d r LF, but
in the Canadian Stock Exchange they are c d v
A Cordova Can. Of course, as a retail operator of
cannabis products. You haven't heard about that in a long time.
It was interesting because cannabis was in favor back and
(33:29):
I'm going to say and and uh Taz you can
correct me on this, but but cannabis was in favor
in twenty twelve, twenty thirteen, twenty fourteen, ran out of favor,
came back in favor, and now it's kind of creating
its own little lane back again. It's almost more established
than before task gate to see pal good good good
to talk to you. What give us an overview of
the whole industry because you have gone through the cyclical
(33:50):
sort of thing in the last decade. Are we now
have a foothold? I mean, I know you guys do
as retail, but do you think the cannabis retail space
is here to stay?
Speaker 3 (34:00):
Yeah?
Speaker 9 (34:00):
No, thanks for having me back, Holly. I it's been
a wild ride. It's you know, to your point, you know,
is in favor in the twenty twelve through whatever twenty
seventeen is timeframe went out went back in and you know,
it's been out of favor for quite some time.
Speaker 1 (34:14):
Uh, you know, we've kept.
Speaker 9 (34:15):
Our head down and just growing the business, but it's
it's been a time when a lot of people have
gone out of business. And now obviously there's a lot
of conversation about uh, you know, decriminalizing the cannabis plant
in the US and and so we'll see if that
actually happens here in the coming weeks. But there's you know,
there's there's certainly a lot of talk about it in
(34:35):
our circle here.
Speaker 3 (34:36):
It's a matter of whether.
Speaker 9 (34:37):
That talk gets a bit of a broader, a broader
reach in the next next few weeks.
Speaker 1 (34:43):
And months, is it still is the lynch pins still
federal banking regulation because as long as cannabis is federally illegal,
not state's rights, but federal, you can't go to a
bank that is FDIC. In short, if you can't do
a FIC assured that you guys have you guys are
hiding cash in your walls and which is dangerous. Uh
(35:04):
is that really what the linchman?
Speaker 3 (35:06):
Is it?
Speaker 1 (35:06):
Once that happens, is this thing is this wild West again?
And then all shows up again in your opinion, Yeah.
Speaker 9 (35:11):
So that's the absolute lynch pin. So just this talk
of descheduling it, rescheduling it is great, but that doesn't
go far enough to where you know, we're treated and
other cannabis businesses are treated as as normal businesses operating
normal widgets and things like that. So so yeah, that's
that's the big that's the big thing that needs to happen.
Speaker 6 (35:29):
Obviously, this this descheduling will help, but it's just the
first step.
Speaker 1 (35:34):
Task Turner, CEO Cordova Can Corporation ticker symbols l v
R l F Canadian Stock Exchange c d v A
tas aside from Canada the United States being on opposite
sides for upcoming World War three? How is the Canadian.
Speaker 2 (35:51):
Government as far as your business is concerned, friend or foe.
Speaker 9 (35:56):
It's relatively friendly. I'd say that the compliance that they
overlay on our industry in Canada is still uh, probably
a little much relative to other industries that are that
are federally you know, watched over, so to speak. So uh,
they certainly are are more friendly and and a lot
more friendly than than what we see in the US,
(36:17):
but there's a long way to go.
Speaker 1 (36:18):
We see that there's still.
Speaker 6 (36:21):
Banks and other institutions even in Canada where it's federally legal,
that give the operators of these businesses and and the
people you know, like myself a hard time, uh to
be to be to be individuals, you know, touching the plant,
even just in Canada.
Speaker 5 (36:38):
Hey, Taz, I'm Mary. I don't think i've met you before.
Nice to meet you, and I thank you. This is
probably a dumb question, but uh, you.
Speaker 1 (36:45):
Know, I know things, dumb questions, but just dumb people
that ask them.
Speaker 5 (36:48):
That's me anyway.
Speaker 3 (36:52):
True.
Speaker 5 (36:53):
In California, we have dispensaries that are around and popping
up everywhere.
Speaker 1 (36:58):
Which is recreational. Correct.
Speaker 5 (37:00):
That means so is that related to what you guys do,
and you guys have anything to do with these dispensaries
and the weed that is sold there.
Speaker 9 (37:08):
Yeah, no, absolutely, So we operate dispensaries in Canada.
Speaker 2 (37:11):
Now.
Speaker 1 (37:12):
We've exited the US for now.
Speaker 9 (37:15):
And obviously have the ability to get back in when
we so choose, But we've exited the US recently and
right now our soul business is operating retail dispensaries in Canada.
Speaker 1 (37:25):
You know, on that question, if you recall and you
and I had this conversation TAZ last year or the
year before whatever, it was probably three years ago when
it went legal here in California. It seemed like we
jumped the shark in terms of getting cannabis legal, not
medicinal cannabinoids, but I'm talking about recreational marijuana use in California,
because there wasn't an infrastructure for safe packaging. There wasn't
(37:46):
a gold standard for if I buy a BAY or
aspirin at CVS, but I buy a CBS aspir at CVS,
I know it's the same thing in terms of those labels.
Do you think that's part of it in terms of
going forward to because when the bank stuff drops, is
there enough infrastructure in the US existing now for those
best practices that didn't exist before. Even though we legalize it,
we didn't have the best practice infrastructure in place.
Speaker 9 (38:07):
It's very fragmented.
Speaker 2 (38:08):
The infrastructure is very fragmented.
Speaker 9 (38:10):
So there's a long way to go in terms of
making the cannabis industry, you know the same as the
bottling industry of Coca Cola or any other CpG you know,
consumer packaging, packaged product, you know that's sold in you know,
the Walmarts and targets of the world. So there's a
long way to go. I also think though that you know,
(38:30):
not only that it's it's a it's a function of
getting the states uh in the same line, you know,
states in line with way the way the federal government's
going to do it, because right now we have thirty
plus states that are all operating differently with all different
compliance programs, and so we're going to directify that as.
Speaker 1 (38:47):
There lies, there lies best practice and gold standard.
Speaker 9 (38:49):
Correct absolutely, right, we gotta we got to you know,
conform to one or two, one or two or three
at most standards.
Speaker 1 (38:57):
Here you got to thirty five.
Speaker 2 (38:58):
It is not good.
Speaker 1 (38:59):
I'm glad that you're on an ongoing basis, Buddy, good
to talk to you, Good to see again. Cast Turner,
CEO Cordova can Corporation, ticker symbol Canadian Stock Exchange c
d v A uh here in the.
Speaker 2 (39:10):
States is l v R l F.
Speaker 1 (39:13):
And that will do it for this version of the Big,
Big Show.
Speaker 2 (39:17):
Thanks to all of you out there for beat along
for the ride. We'll see you again soon
Popular Podcasts
Stuff You Should Know
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.
Law & Order: Criminal Justice System - Season 1 & Season 2
Season Two Out Now! Law & Order: Criminal Justice System tells the real stories behind the landmark cases that have shaped how the most dangerous and influential criminals in America are prosecuted. In its second season, the series tackles the threat of terrorism in the United States. From the rise of extremist political groups in the 60s to domestic lone wolves in the modern day, we explore how organizations like the FBI and Joint Terrorism Take Force have evolved to fight back against a multitude of terrorist threats.
Dateline NBC
Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com